Among the potential tumor microenvironmental factors driving the transformation of immunostimulatory DCs into immunosuppressive players, we identified that at least PGE2 and TGF-β (but not IL-6) in supernatants from primary cultures, are both necessary to elicit a regulatory phenotypic switch in DCs from early tumors. This evidence concerns the gene TGFB1 and neoplasm.